Journal of Clinical Oncology · 2005 · 126 citations · 24 references
MYCN deregulation is a feature of rhabdomyosarcoma tumorigenesis, defines groups of patients with a poor prognosis, and is a potential target for novel therapies.
24
Paul S. Knoepfler, Pei Cheng, Robert N. Eisenman · Genes & Development · 2002 · 504 citations · Full text